Pubblicazioni

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study

2024 - THROMBOSIS AND HAEMOSTASIS
Ortega-Paz, Luis; Franchi, Francesco; Rollini, Fabiana; Galli, Mattia; Been, Latonya; Ghanem, Ghussan; Shalhoub, Awss; Ossi, Tiffany; Rivas, Andrea; Zhou, Xuan; Pineda, Andres M.; Suryadevara, Siva; Soffer, Daniel; Zenni, Martin M.; Jennings, Lisa K.; Angiolillo, Dominick J.

The 2024 ESC Guidelines for diagnosis and management of AF: A clinicians’ perspective

2024 - THROMBOSIS AND HAEMOSTASIS
Potpara, Tatjana S; Romiti, Giulio Francesco; Sohns, Christian

Open Issues in the choice and management of direct oral anticoagulants in patients with cancer-related venous thromboembolism

2024 - THROMBOSIS AND HAEMOSTASIS
Pastori, Daniele; Palareti, Gualtiero

Educational attainment, obesity, and venous thromboembolism. is only matter of weight

2024 - THROMBOSIS AND HAEMOSTASIS
Pastori, Daniele; Sciacqua, Angela

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma